Patents by Inventor Wendy S. Garrett

Wendy S. Garrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis
    Patent number: 10383921
    Abstract: Disclosed herein are compositions and methods for providing an antioxidant effect to a subject, e.g., modulating or otherwise improving oxidative stress pathways and/or neutralizing or reducing damaging reactive oxygen species (ROS).
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: August 20, 2019
    Assignees: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, COMPAGNIE GERVAIS DANONE
    Inventors: Wendy S. Garrett, Patrick Veiga, Sonia Arora Ballal, Johan van Hylckama Vlieg, Gaëlle Quéré, Peggy Garault
  • Modulation of regulatory T cells via G-coupled protein receptor 43
    Patent number: 10105329
    Abstract: Disclosed herein are compositions and methods that are useful for inducing the development of regulatory T cells (Treg). Such compositions and methods are useful for treating inflammatory conditions and in particular inflammatory conditions affecting the gastrointestinal tract of a subject. In certain embodiments, the present inventions generally relate to short chain fatty acids and the discovery that such short chain fatty acids may be used to treat and/or prevent inflammatory conditions by enhancing the size and immune function of a subject's endogenous Treg population.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: October 23, 2018
    Assignee: President and Fellows of Harvard College
    Inventors: Wendy S. Garrett, Patrick M. Smith
  • MODULATION OF REGULATORY T CELLS VIA G-COUPLED PROTEIN RECEPTOR 43
    Publication number: 20170340588
    Abstract: Disclosed herein are compositions and methods that are useful for inducing the development of regulatory T cells (Treg). Such compositions and methods are useful for treating inflammatory conditions and in particular inflammatory conditions affecting the gastrointestinal tract of a subject. In certain embodiments, the present inventions generally relate to short chain fatty acids and the discovery that such short chain fatty acids may be used to treat and/or prevent inflammatory conditions by enhancing the size and immune function of a subject's endogenous Treg population.
    Type: Application
    Filed: June 22, 2017
    Publication date: November 30, 2017
    Inventors: Wendy S. Garrett, Patrick M. Smith
  • Method of increasing the quantity of colonic T regulatory cells via G-coupled protein receptor 43
    Patent number: 9693977
    Abstract: Disclosed herein are compositions and methods that are useful for inducing the development of regulatory T cells (Treg). Such compositions and methods are useful for treating inflammatory conditions and in particular inflammatory conditions affecting the gastrointestinal tract of a subject. In certain embodiments, the present inventions generally relate to short chain fatty acids and the discovery that such short chain fatty acids may be used to treat and/or prevent inflammatory conditions by enhancing the size and immune function of a subject's endogenous Treg population.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: July 4, 2017
    Assignee: President and Fellows of Harvard College
    Inventors: Wendy S. Garrett, Patrick M. Smith
  • LEVERAGING OXIDATIVE STRESS PATHWAYS IN LACTIC ACID BACTERIA TO PROMOTE GUT HOMEOSTASIS
    Publication number: 20160193303
    Abstract: Disclosed herein are compositions and methods for providing an antioxidant effect to a subject, e.g., modulating or otherwise improving oxidative stress pathways and/or neutralizing or reducing damaging reactive oxygen species (ROS).
    Type: Application
    Filed: August 13, 2014
    Publication date: July 7, 2016
    Inventors: Wendy S. Garrett, Patrick Veiga, Sonia Arora Ballal, Johan van Hylckama Vlieg, Gaëlle Quéré, Peggy Garault
  • MODULATION OF REGULATORY T CELLS VIA G-COUPLED PROTEIN RECEPTOR 43
    Publication number: 20160038447
    Abstract: Disclosed herein are compositions and methods that are useful for inducing the development of regulatory T cells (Treg). Such compositions and methods are useful for treating inflammatory conditions and in particular inflammatory conditions affecting the gastrointestinal tract of a subject. In certain embodiments, the present inventions generally relate to short chain fatty acids and the discovery that such short chain fatty acids may be used to treat and/or prevent inflammatory conditions by enhancing the size and immune function of a subject's endogenous Treg population.
    Type: Application
    Filed: March 17, 2014
    Publication date: February 11, 2016
    Applicant: President and Fellows of Harvard College
    Inventors: Wendy S. Garrett, Patrick M. Smith
  • Method for reducing gastro-intestinal inflammation using bacteria or a fermented dairy product comprising such bacteria
    Patent number: 8685388
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: April 1, 2014
    Assignees: Compagnie Gervais Danone, President and Fellows of Harvard College
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett
  • Method for Reducing Gastro-Intestinal Inflammation Using Bifidobacterium Animalis Bacteria or a Fermented Dairy Product Comprising Such Bacteria
    Publication number: 20120308523
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Application
    Filed: November 2, 2009
    Publication date: December 6, 2012
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, COMPAGNIE GERVAIS DANONE
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett